IMES becomes one of three new sites in the Massachusetts Digital Health R&D Sandbox Program
Massachusetts expands Digital Health R&D Sandbox Program, adds sites in Cambridge, Boston, and western Massachusetts The MIT Institute for Medical Engineering and Science (IMES) has become one of the three, new, healthcare R&D hub sites selected by the Massachusetts eHealth Institute at MassTech (MeHI), joining the Digital Health Sandbox Network….
Read MoreThe Sekisui House at MIT: Addressing the growing challenge of the special needs of the aging
A collaboration between MIT’s Institute of Medical Engineering and Science (IMES) and Sekisui House of Japan will investigate in-home wellness monitoring CAMBRIDGE, Mass. – To address the growing problem of an aging population, in Japan and around the world, MIT’s Institute of Medical Engineering and Science (IMES) and the Sekisui…
Read More2019 IDEA2 Global program transforms new group of medical innovators
From June 20-21, 13 select teams of entrepreneurs, doctors, and researchers from countries including Spain, Chile, Canada, and the U.S. gathered to participate in the 2019 MIT LinQ IDEA2 Global program. Teams worked with technology experts and entrepreneurs from elite institutions in the Boston area and throughout the world alongside…
Read MoreMIT linQ Announces 2019 Class of IDEA2 Global
Contact Eric Norman MIT linQ Communications enorman@mit.edu 14 international teams developing new biomedical technologies Teams win seven-month innovation training and project mentoring from innovators at MIT and other world-class institutions New technologies for a range of unmet medical needs, including a painless microneedle patch for treating pediatric asthma and novel…
Read MoreSongs of KwaZulu-Natal: Reflections from HST.434
This past January, we traveled to South Africa as part of the IAP class HST.434: Evolution of an Epidemic. The class, taught by IMES Professor Bruce Walker and Dr. Howard Heller and offered to MIT undergraduates, examines the medical, scientific, public health and policy responses to a new disease, by…
Read More